Roche’s combo lymphoma treatment wins U.S. FDA approval
The U.S. Food and Drug Administration on Monday granted earlier-than-expected approval to Roche Holding AG's antibody-drug conjugate Polivy for treatment of patients with advanced lymphoma. Reuters Health News
In Charge of Animal Disease Study, and Surveillance Bureau, expert on Disease Study, Surveillance, Early Warning/Response, Client Training, and Development. Executive Officer for projects avoiding spread of diseases. Works at Iran Veterinary Organization; Veterinarian, 2000 - present.